WEE1 and prostate neoplasm: To fully exploit the therapeutic potential of WEE1 inhibition, we further examined the effectiveness of AZD1775 in a mouse survival experiment, in which treatment was initiated upon the development of palpable primary prostate tumors and continued until death or humane moribund endpoints.